[8] 柯昌虎，邊曉麗.煙酸受體GPR109a及相關激動劑的研究進展[J].中國藥物化學雜誌，2012（5）：424.
[9] 崔永梅，南發俊.生物電子等排原理在藥物先導化合物優化中的應用[J].生命科學，2006（2）：161.
[10] 陸紹永，蔣勇軍，俞慶森，等. G-蛋白偶聯受體GPR120分子模建研究[J].化學學報，2009，14：1553.
[11] 徐陽，劉培勳，龍偉. GPCR的計算機模擬研究[J].生命的化學，2009（3）：422.
[12] Deng Q， Frie J L， Marley D M， et al. Molecular modeling aided design of nicotinic acid receptor GPR109A agonists[J].Bioorg Med Chem Lett， 2008，18（18）：4963.
[13] 司曉芸，吳小燕，賈汝漢.纈草油對高膽固醇血症大鼠腎小球足細胞損傷的影響[J].醫藥導報，2009（9）：1117.
[14] 司曉芸，吳小燕，賈汝漢.纈草油對高膽固醇血症大鼠腎小管上皮細胞巢蛋白表達的影響[J].中國中西醫結合腎病雜誌，2010（6）：486.
[15] 袁列江，李忠海，鄭錦星.檳榔提取物對大白鼠血脂調節作用的研究[J].食品科技，2009（2）：188.
[16] 鄭誌民.檳榔堿調節IR大鼠脂肪APN、HO-1和骨骼肌GLUT4的表達改善IR[D].衡陽：南華大學，2009.
[17] 金成海.草蓯蓉對動脈粥樣硬化的保護作用[D].延邊：延邊大學，2008.
[18] 尹學哲，許惠仙，金愛花，等.草蓯蓉對高脂血症兔血脂和抗氧化能力影響[J].中國公共衛生，2010，10：1290.
[19] 馮群，欒永福，孫蓉.基於功效和物質基礎的雷公藤毒性研究進展[J].中國藥物警戒，2013（2）：88.
Discovery of potential nicotinic acid receptor agonists from Chinese
herbal medicines based on molecular simulation
JIANG Lu-di， HE Yu-su， ZHANG Yan-ling*
（Research Center of Traditional Chinese Medicine Information Engineering， Beijing University of
Chinese Medicine， Beijing 100102， China）
[Abstract] Nicotinic acid could increase high density lipoprotein and reduce serum total cholesterol， low density lipoprotein cholesterol and triglycerides in human bodies， thus is frequently applied in treating low high-density lipoprotein cholesterol and hypertriglyceridemia in clinic. However， according to the findings， nicotinic acid could also cause adverse effects， such as skin flush， beside its curative effects. In this study， bioisosterism， fragment-based search and Lipinski′s Rule of Five were used to preliminarily screen out potential TCM ingredients that may have similar pharmacological effects with nicotinic acid from Traditional Chinese medicine database （TCMD）. Afterwards， homology modeling and flexible docking were used to further screen out potential nicotinic acid receptor agonists. As a result， eleven candidate compounds were derived from eight commonly used traditional Chinese medicines. Specifically， all of the candidate compounds′ interaction with nicotinic acid receptor was similar to nicotinic acid， and their docking scores were all higher than that of nicotinic acid， but their druggability remained to be further studied. Some of the eight source traditional Chinese medicines were used to lower lipid according to literature studies， implying that they may show effect through above means. In summary， this study provides basis and reference for extracting new nicotinic acid receptor agonists from traditional Chinese medicines and improving the medication status of hyperlipidemia.
[Key words] nicotinic acid receptor agonist； bioisosterism； fragment-based search； traditional Chinese medicine； molecular docking； hyperlipidemia
doi：10.4268/cjcmm20142333
[責任編輯 丁廣治]